טוען...
Rare anaemias, sickle-cell disease and COVID-19
For rare haematological diseases (RHD), the first question to be answered is if patients with benign red blood cell (RBC) defects like haemoglobinopathies, membranopathies and enzymopathies are more vulnerable to COVID-19 infection. Up to now, there is no yet literature on the subject, but, like in...
שמור ב:
| הוצא לאור ב: | Acta Biomed |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Mattioli 1885
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7569637/ https://ncbi.nlm.nih.gov/pubmed/32420949 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.23750/abm.v91i2.9532 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|